Revenue (Tables)

9 Months Ended

Sep. 30, 2020

Revenue from Contract with Customer [Abstract]

Disaggregation of Revenue [Table Text Block]

The following table represents our revenues disaggregated by geography (in thousands):

	For the three months ended September 30,				For the nine months ended September 30,
Geography	2020		2019		2020		2019
Europe, the Middle East and Africa	$	32,596	$	31,474	$	99,107	$	96,830
Other Foreign	48,525		53,398		175,618		156,353
Total Foreign	81,121		84,872		274,725		253,183
United States	237,446		222,599		675,828		697,502
Total Revenues	$	318,567	$	307,471	$	950,553	$	950,685

    The following table represents our revenues disaggregated by product (in thousands):

	For the three months ended September 30,				For the nine months ended September 30,
Product line	2020		2019		2020		2019
Infusion Consumables	$	116,054	$	119,745	$	350,554	$	357,994
Infusion Systems	88,388		78,932		267,856		244,523
IV Solutions	101,900		98,159		295,369		313,976
Critical Care	12,225		10,635		36,774		34,192
Total Revenues	$	318,567	$	307,471	$	950,553	$	950,685

Contract with Customer, Asset and Liability [Table Text Block]

The following table presents our changes in the contract balances for the nine months ended September 30, 2020 and 2019 (in thousands):

	Contract Liabilities
Beginning balance, January 1, 2020	$	(4,855)
Equipment revenue recognized	9,920
Equipment revenue deferred due to implementation	(13,679)
Software revenue recognized	4,715
Software revenue deferred due to implementation	(5,033)
Ending balance, September 30, 2020	$	(8,932)
Beginning balance, January 1, 2019	$	(4,282)
Equipment revenue recognized	3,619
Equipment revenue deferred due to implementation	(6,869)
Software revenue recognized	2,955
Software revenue deferred due to implementation	(3,115)
Ending balance, September 30, 2019	$	(7,692)